This course has expired. View available courses.
Infectious Disease
Implementing IMD Serogroup B Vaccination for Pediatric Patients
Invasive meningococcal disease (IMD) is an acute and serious disease that can result in death. Key differences exist between the IMD vaccines that are available in Canada, such as the meningococcal serogroups that they protect against and the age indications for use.
Using a pediatric patient case, this program will review the prevalence of different meningococcal serogroups in Canada, along with the differences between currently available vaccines. The overall goal of the program is to increase clinicians’ confidence in discussing IMD vaccination with their patients and recommending appropriate vaccination.
DURATION
15 min
PROFESSION
Physician
# OF CREDITS
0.25
ACCREDITATION
Mainpro+
EXPIRY DATE
2023-06-27
Invasive meningococcal disease (IMD) is an acute and serious disease that can result in death. Key differences exist between the IMD vaccines that are available in Canada, such as the meningococcal serogroups that they protect against and the age indications for use.
Using a pediatric patient case, this program will review the prevalence of different meningococcal serogroups in Canada, along with the differences between currently available vaccines. The overall goal of the program is to increase clinicians’ confidence in discussing IMD vaccination with their patients and recommending appropriate vaccination.
This CME has been supported by educational funding from GSK Grant.
Faculty
James Kim, MBBCh, PgDip
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Marla Shapiro, C.M.
Angel Chu, CCFP, MHSc, FRCPC, FCFP, NCMP
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Discuss the clinical significance of invasive meningococcal disease (IMD).
- Describe the prevalence of different meningococcal serogroups in Canada.
- Differentiate between the currently available vaccines for IMD.
- Summarize the real word evidence gathered from the use of 4CMenB.
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ Credits.
This program is developed in collaboration with Partners in Progressive Medical Education (PPME).
#
of credits: 0.25
Duration: 15 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
15 min
Duration
Physician
Profession
0.25
# of credits
Learning Objectives
Upon completion of this continuing education program participants will be better able to:
- Discuss the clinical significance of invasive meningococcal disease (IMD).
- Describe the prevalence of different meningococcal serogroups in Canada.
- Differentiate between the currently available vaccines for IMD.
- Summarize the real word evidence gathered from the use of 4CMenB.
Mainpro+
ACCREDITATION
Infectious Disease
Learning Category
Meningitis
Topic
0
Price
2023-06-27
Expiry Date
CAN-eng
Region/Language
Course Description
Invasive meningococcal disease (IMD) is an acute and serious disease that can result in death. Key differences exist between the IMD vaccines that are available in Canada, such as the meningococcal serogroups that they protect against and the age indications for use.
Using a pediatric patient case, this program will review the prevalence of different meningococcal serogroups in Canada, along with the differences between currently available vaccines. The overall goal of the program is to increase clinicians’ confidence in discussing IMD vaccination with their patients and recommending appropriate vaccination.
This CME has been supported by educational funding from GSK Grant.
Faculty
James Kim, MBBCh, PgDip
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Marla Shapiro, C.M.
Angel Chu, CCFP, MHSc, FRCPC, FCFP, NCMP
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.25 Mainpro+ Credits.
This program is developed in collaboration with Partners in Progressive Medical Education (PPME).
15 min
Duration
0
Price
0.25
# of credits
